[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
September 8, 1999

Human Genome Studies Expected to Revolutionize Cancer Classification

Author Affiliations

Not Available

Not Available

JAMA. 1999;282(10):927-928. doi:10.1001/jama.282.10.927

Bar Harbor, Me—The National Cancer Institute (NCI) is launching a major effort aimed at revolutionizing how tumors are classified, a venture that has far-reaching implications for how physicians will diagnose and treat cancer in the future.

A refined classification scheme that will reflect important differences in the molecular makeup of tumors—differences that are mostly unknown to today's pathologists—will help researchers find better ways to prevent and treat various forms of cancer, said NCI Director Richard Klausner, MD. He described the initiative at a press briefing held here in connection with a conference on "The Genetics Revolution in the New Millennium," sponsored by the Jackson Laboratory and Johns Hopkins University.